Trial
NCT03024437
Atezolizumab in Combination With Entinostat and Bevacizumab in Patients With Advanced Renal Cell Carcinoma
Phase ITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Roberto Pili
Collaborators
Genentech, Inc.; Syndax Pharmaceuticals
Condition
Metastatic Cancer
Intervention
Atezolizumab
Why stopped
Genentech has closed the study due to lack of data with Atezo
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-03-20